May 22, 2025
Medication non-adherence costs the U.S. $500B annually. Pleio’s new AI, OLLIE, identifies emotional barriers through patient conversation analysis, empowering human supporters to intervene with empathy and improve outcomes.
May 7, 2025
Jen Butler, chief commercial officer at Pleio, and Mark Gregory, chief pharmacy officer at Pleio, sat down for an interview with Pharmacy Times at Asembia’s AXS25 Summit. They discussed the critical role of emotional support in specialty pharmacy. Drawing on insights from a recent report, Butler and Gregory highlighted the importance of addressing patient barriers in improving medication adherence.
April 30, 2025
Findings of a new report from Pleio, Loneliness and Health Behaviors: A Missing Link in Chronic Care, highlight emotional disengagement as a largely overlooked clinical risk that compromises chronic care management.
April 29, 2025
AJMC highlights a new report from Pleio that reveals a strong connection between loneliness and chronic illness. The findings show that social isolation worsens physical health, contributes to medication nonadherence, and drives up healthcare costs. The report underscores the urgent need to address loneliness as a serious threat to both mental and physical well-being.
April 28, 2025
Gentry Health Services and Pleio released results from their pilot patient support program, which is actively reshaping medication adherence and patient engagement. By integrating emotional support and peer connections into specialty pharmacy care, the program significantly improved patient experience, retention, and outcomes.
April 28, 2025
“We commissioned this report to understand the emotional realities behind medication non-adherence. Now we have the data to prove it — loneliness isn’t just hurting patients emotionally, it’s putting their health at risk” – Michael Oleksiw, CEO at Pleio
FOR MEDIA INQUIRIES PLEASE EMAIL [email protected].